Cargando…

Chitin : fulfilling a biomaterials promise /

The second edition of Chitin underscores the important factors for standardizing chitin processing and characterization. It captures the essential interplay between chitin's assets and limitations as a biomaterial, placing the past promises of chitin in perspective, addressing its present reali...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Khor, Eugene
Otros Autores: Wan, Andrew C. A.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Waltham, MA : Elsevier, 2014.
Edición:2nd ed.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_ocn881510317
003 OCoLC
005 20231120111610.0
006 m o d
007 cr |n|||||||||
008 140620s2014 mau ob 000 0 eng d
040 |a IDEBK  |b eng  |e rda  |e pn  |c IDEBK  |d CDX  |d OPELS  |d EBLCP  |d N$T  |d E7B  |d OCLCF  |d OCLCQ  |d DEBSZ  |d OCLCO  |d DIBIB  |d OCLCO  |d OCLCQ  |d OCLCO  |d ITD  |d OCLCQ  |d BUF  |d OCLCQ  |d U3W  |d D6H  |d OTZ  |d OCLCQ  |d AUD  |d OCLCQ  |d S2H  |d OCLCO  |d UX1  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 881571052 
020 |a 1306874661  |q (electronic bk.) 
020 |a 9781306874663  |q (electronic bk.) 
020 |a 9780080999395  |q (electronic bk.) 
020 |a 0080999395  |q (electronic bk.) 
020 |a 9780080999401  |q (electronic bk.) 
020 |a 0080999409  |q (electronic bk.) 
035 |a (OCoLC)881510317  |z (OCoLC)881571052 
050 4 |a QD321 
060 4 |a 2015 E-754 
060 4 |a QU 83 
072 7 |a SCI  |x 013060  |2 bisacsh 
072 7 |a TEC  |x 009010  |2 bisacsh 
082 0 4 |a 610.3  |b 23 
100 1 |a Khor, Eugene. 
245 1 0 |a Chitin :  |b fulfilling a biomaterials promise /  |c by Eugene Khor ; with Andrew C.A. Wan. 
250 |a 2nd ed. 
264 1 |a Waltham, MA :  |b Elsevier,  |c 2014. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
520 |a The second edition of Chitin underscores the important factors for standardizing chitin processing and characterization. It captures the essential interplay between chitin's assets and limitations as a biomaterial, placing the past promises of chitin in perspective, addressing its present realities and offering insight into what is required to realize chitin's destiny (including its derivative, chitosan) as a biomaterial of the twenty-first century. This book is an ideal guide for both industrialists and researchers with a vested interest in commercializing chitin. 
504 |a Includes bibliographical references. 
504 |a References6 Chitin and Chitosan Relative to Collagen and Hyaluronan; 6.1 Preliminary comments; 6.2 Brief overview of collagen; 6.3 Brief overview of hyaluronan; 6.4 Survey of chitin with collagen and hyaluronan; 6.4.1 Chitosan and collagen; 6.4.2 Chitosan and HA; 6.4.3 Chitosan with collagen and HA; 6.5 Trends; References; 7 Chitin and Chitosan: Making the Grade; 7.1 What is Medical Grade?; 7.2 Obtaining ready-to-use materials7; 7.2.1 Chitin raw materials; 7.2.2 Chitin pretreatment; 7.2.3 Chitin isolation; 7.3 Purity and quality; 7.3.1 Criteria for acceptance-purity. 
505 0 |a Front Cover; Chitin: Fulfilling a Biomaterials Promise; Copyright Page; Contents; Acknowledgments; About the Author; Background; Preface to the Second Edition; Format; Comments on literature survey and references; Preface to the First Edition; 1 Overview of Chitin and Chitosan Research; 1.1 The Golden Era; 1.2 Generational transition; 1.3 Key outcomes of chitin and chitosan research to date; 1.3.1 Production of raw materials; 1.3.2 Characterization and structural studies; 1.3.3 Chemistry; 1.3.4 Nonbiomedical applications; 1.3.4.1 Industrial; 1.3.4.2 Waste treatment/heavy metal recovery. 
505 8 |a 1.3.4.3 Crops and food preservation1.4 Trends; 1.4.1 Toward ready-to-use; 1.4.2 Toward quantitative determinations; 1.4.3 Toward versatility in properties; 1.4.4 Toward commercial applications; Summary; References; 2 Chitosan Biomedical Commercialization; 2.1 Preliminary comments; 2.2 Survey of commercial chitin/chitosan enterprises: demise, disputes, perennials, and new players; 2.2.1 BioSyntech; 2.2.2 Hemcon; 2.2.3 MPT; 2.2.4 Medovent; 2.2.5 Novamatrix-FMC Biopolymer; 2.2.6 Heppe medical chitosan GmbH; 2.2.7 Kitozyme; 2.2.8 Chinese producers. 
505 8 |a 2.2.8.1 Qingdao Hong Hai Bio-Tech Co., Ltd. and Qingdao BZ Oligo Biotech Co., Ltd. 2.2.8.2 Zhejiang Ao Xing Biotechnology Co., Ltd.; 2.2.9 Other chitin producers; 2.3 Trends; 2.3.1 Commercial outlook; 2.3.2 Research implications; Summary; References; 3 Traditional Chitin and Chitosan Biomaterials Research; 3.1 Preliminary comments; 3.2 Survey; 3.2.1 Wound dressings; 3.2.2 Bone substitutes; 3.2.3 Blood interactions; 3.2.4 Chitosan as the carrier/delivery system for pharmaceuticals and biological materials; 3.2.5 Antimicrobial agents; 3.3 Trends; References. 
505 8 |a 4 Chitin and Chitosan Tissue Engineering and Stem Cell Research4.1 Preliminary comments; 4.2 Survey; 4.2.1 TE overview; 4.2.2 TE survey; 4.2.3 SC survey; 4.3 Trends; 4.3.1 Biomaterials/scaffolds technology going forward; 4.3.2 Technology, product development, and manufacturing; 4.3.3 TE and SC regulatory perspective; 4.3.4 What now for chitin?; References; 5 The Impact of Nanotechnology on Chitin and Chitosan Biomaterials Research; 5.1 Preliminary comments; 5.2 Survey; 5.2.1 Nanofibers; 5.2.2 Nanoparticles; 5.2.3 Nanocombinations; 5.2.4 Biomedical applications that utilize chitin; 5.3 Trends. 
650 0 |a Chitin  |x Biotechnology. 
650 6 |a Chitine  |0 (CaQQLa)201-0065330  |x Biotechnologie.  |0 (CaQQLa)201-0378829 
650 7 |a SCIENCE  |x Chemistry  |x Industrial & Technical.  |2 bisacsh 
650 7 |a TECHNOLOGY & ENGINEERING  |x Chemical & Biochemical.  |2 bisacsh 
650 7 |a Chitin  |x Biotechnology  |2 fast  |0 (OCoLC)fst00857992 
700 1 |a Wan, Andrew C. A. 
776 0 8 |i Print version:  |z 9781306874663 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780080999395  |z Texto completo